Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea
· Delayed Price · Currency is KRW
8,310.00
+400.00 (5.06%)
Mar 10, 2026, 11:28 AM KST
Komipharm International Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 572,224 | 267,413 | 293,942 | 446,056 | 548,450 | 858,749 | |
| Market Cap Growth | 110.44% | -9.03% | -34.10% | -18.67% | -36.13% | -11.44% | |
| Enterprise Value | 587,690 | 289,788 | 324,970 | 476,056 | 565,527 | 878,631 | |
| Last Close Price | 7910.00 | 3860.00 | 4190.00 | 6350.57 | 7804.20 | 12219.61 | |
| PE Ratio | - | 20.39 | - | - | - | - | |
| PS Ratio | 10.16 | 4.55 | 6.89 | 11.21 | 15.30 | 23.11 | |
| PB Ratio | 7.64 | 4.08 | 4.90 | 6.80 | 7.58 | 11.00 | |
| P/TBV Ratio | 8.14 | 4.43 | 5.22 | 7.36 | 8.26 | 11.27 | |
| P/FCF Ratio | - | 34.28 | - | - | - | - | |
| P/OCF Ratio | 376.25 | 30.23 | - | - | - | 34076.71 | |
| EV/Sales Ratio | 10.44 | 4.93 | 7.62 | 11.96 | 15.78 | 23.64 | |
| EV/EBITDA Ratio | 103.79 | 31.18 | - | 21308.58 | - | 561.53 | |
| EV/EBIT Ratio | 227.99 | 46.79 | - | - | - | - | |
| EV/FCF Ratio | -1625.94 | 37.14 | - | - | - | - | |
| Debt / Equity Ratio | 0.55 | 0.67 | 0.75 | 0.58 | 0.46 | 0.46 | |
| Debt / EBITDA Ratio | 7.25 | 4.72 | - | 1706.78 | - | 22.80 | |
| Debt / FCF Ratio | - | 5.62 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.17 | 0.33 | 0.51 | 0.42 | 0.27 | 0.24 | |
| Net Debt / EBITDA Ratio | 2.23 | 2.30 | -11.04 | 1223.16 | -11.41 | 11.86 | |
| Net Debt / FCF Ratio | -34.87 | 2.74 | -8.81 | -10.29 | -9.42 | -11.38 | |
| Asset Turnover | 0.42 | 0.49 | 0.37 | 0.35 | 0.30 | 0.30 | |
| Inventory Turnover | 2.37 | 2.52 | 1.93 | 1.87 | 1.77 | 1.83 | |
| Quick Ratio | 1.36 | 0.83 | 0.52 | 0.53 | 0.93 | 0.72 | |
| Current Ratio | 2.03 | 1.30 | 0.96 | 1.01 | 1.61 | 1.14 | |
| Return on Equity (ROE) | -4.71% | 23.40% | -9.41% | -10.84% | -7.89% | -5.13% | |
| Return on Assets (ROA) | 1.21% | 3.21% | -3.40% | -2.09% | -2.79% | -1.10% | |
| Return on Capital Employed (ROCE) | 2.60% | 8.10% | -9.50% | -5.40% | -5.90% | -2.60% | |
| Earnings Yield | -0.44% | 4.90% | -1.35% | -1.46% | -0.81% | -0.33% | |
| FCF Yield | -0.06% | 2.92% | -1.17% | -0.60% | -0.38% | -0.19% | |
| Buyback Yield / Dilution | -1.54% | 0.66% | 0.18% | -0.01% | -0.09% | -0.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.